Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Stevens

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|March 10, 2012
NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patientsSally Doss, Zoe Garrett, Frances Sutcliffe, et al.
International Journal of Technology Assessment in Health Care|December 22, 2004
Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with needClaire Packer, Andrew Stevens, Alison Cook, et al.
The Lancet. Oncology|March 4, 2015
NICE guidance on axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatmentNwamaka Umeweni, Boglarka Mikudina, Frances Sutcliffe, et al.
The Lancet. Oncology|April 16, 2011
NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinomaChristian Griffiths, Nicola Hay, Frances Sutcliffe, et al.
The Lancet. Oncology|January 17, 2013
NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumoursAnwar Jilani, Zoe Garrett, Frances Sutcliffe, et al.
International Journal of Technology Assessment in Health Care|June 21, 2007
Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systemsKieran Murphy, Claire Packer, Andrew Stevens, et al.
International Journal of Technology Assessment in Health Care|December 22, 2004
Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: case studyAlison Cook, Claire Packer, Andrew Stevens, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|September 27, 2016
Accuracy of pharmaceutical company licensing predictions: projected versus actual licensing datesLucy Doos, Derek Ward, Andrew Stevens, et al.
Iscience|March 14, 2022
Dopamine neuron stimulation induces context-dependent abnormal involuntary movements in healthy ratsJulia Hunter, Alexandra Bova, Andrew Stevens, et al.
Scientific Reports|September 9, 2018
Single-shot memory-effect videoXiaohan Li, Andrew Stevens, Joel A Greenberg, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|March 10, 2012
NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patientsSally Doss, Zoe Garrett, Frances Sutcliffe, et al.
International Journal of Technology Assessment in Health Care|December 22, 2004
Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with needClaire Packer, Andrew Stevens, Alison Cook, et al.
The Lancet. Oncology|March 4, 2015
NICE guidance on axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatmentNwamaka Umeweni, Boglarka Mikudina, Frances Sutcliffe, et al.
The Lancet. Oncology|April 16, 2011
NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinomaChristian Griffiths, Nicola Hay, Frances Sutcliffe, et al.
The Lancet. Oncology|January 17, 2013
NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumoursAnwar Jilani, Zoe Garrett, Frances Sutcliffe, et al.
International Journal of Technology Assessment in Health Care|June 21, 2007
Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systemsKieran Murphy, Claire Packer, Andrew Stevens, et al.
International Journal of Technology Assessment in Health Care|December 22, 2004
Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: case studyAlison Cook, Claire Packer, Andrew Stevens, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|September 27, 2016
Accuracy of pharmaceutical company licensing predictions: projected versus actual licensing datesLucy Doos, Derek Ward, Andrew Stevens, et al.
Iscience|March 14, 2022
Dopamine neuron stimulation induces context-dependent abnormal involuntary movements in healthy ratsJulia Hunter, Alexandra Bova, Andrew Stevens, et al.
Scientific Reports|September 9, 2018
Single-shot memory-effect videoXiaohan Li, Andrew Stevens, Joel A Greenberg, et al.
Pageof 9